FIT vs gFOBTs: What’s changed? 

Friday 18th October 2019

The new Faecal Immunochemical Test (FIT) rolled out across England this year has a number of benefits in replacing the use of older guaiac-based faecal occult blood tests (gFOBTs). Is your practice up to date with the new processes associated with FIT and are you aware of the reasons for the change?

Our latest course on Faecal Immunochemical Testing (FIT) is now available, outlining the use of FIT as a screening tool and appropriate use for symptomatic patients. It also includes some of the key benefits of changing to this method from gFOBTs, including:

  • Increased reliability as an indicator of abnormal pathology
  • The need for one patient sample only, compared to the previous three
  • Using antibodies that specifically recognise human haemoglobin
  • Reducing the number of repeat tests, as there are no borderline results (only normal or abnormal)

Find out more:

Find out more: visit the GatewayC Faecal Immunochemical Test course here. 1 CPD credit is available upon completion of this course.

Keep up to date: Twitter | Facebook | LinkedIn

Latest from the Blog

Cancer Keys: Myeloma and C.R.A.B

Cancer Keys: Myeloma and C.R.A.B

Myeloma and C.R.A.B C.R.A.B is the acronym designed to simplify the most typical clinical manifestations of multiple myeloma. Clinicians should consider the following indicators in a potential myeloma diagnosis: C: Calcium - hypercalcaemia R: Renal – any form of renal...

read more

Related Posts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.